Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.bajajhealth.com | |
Market Cap | 840.37 Cr. | |
Enterprise Value(EV) | 1,161.41 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 20.62 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 14.77 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 31.86 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 133.31 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 2.28 | Calculated using Price: 304.50 |
Dividend Yield | 0.49 | Period Ending 2022-03 |
No. of Shares Subscribed | 2.76 Cr. | 27,598,400 Shares |
FaceValue | 5 | |
About Bajaj Healthcare Ltd. | ||
Bajaj Healthcare is a pharmaceutical company with manufacturing and marketing capabilities in Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins, Amino Acids, Anti-Convulsants and Finished Dosage Forms (FDFs) caters to various therapeutic segments. |
1 Day |
|
-0.60% |
1 Week |
|
-0.60% |
1 Month |
|
-1.89% |
3 Month |
|
-11.86% |
6 Month |
|
-21.30% |
1 Year |
|
-2.75% |
2 Year |
|
-10.07% |
5 Year |
|
+179.54% |
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 7.31 | 22.38 | 19.60 | 10.77 | 17.68 | 20.18 | 18.92 | 38.09 | 24.33 | |
Return on Capital Employed (%) | 10.67 | 19.16 | 18.00 | 14.52 | 18.25 | 19.75 | 19.47 | 35.91 | 20.00 | |
Return on Assets (%) | 1.53 | 4.50 | 4.12 | 3.65 | 6.23 | 6.10 | 8.28 | 19.14 | 11.45 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 31 | 82 | 89 | 99 | 114 | 129 | 178 | 258 | 328 | 357 | |
Non Curr. Liab. | 14 | 22 | 32 | 28 | 23 | 20 | 27 | 85 | 71 | 69 | |
Curr. Liab. | 99 | 85 | 88 | 93 | 131 | 117 | 138 | 183 | 322 | 400 | |
Minority Int. | |||||||||||
Equity & Liab. | 145 | 189 | 209 | 219 | 268 | 267 | 343 | 526 | 721 | 826 | |
Non Curr. Assets | 59 | 110 | 131 | 128 | 129 | 130 | 175 | 267 | 323 | 356 | |
Curr. Assets | 86 | 79 | 78 | 91 | 140 | 137 | 168 | 258 | 398 | 469 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 145 | 189 | 209 | 219 | 268 | 267 | 343 | 526 | 721 | 826 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 186 | 197 | 200 | 207 | 290 | 325 | 410 | 657 | 680 | 691 | |
Other Income | 0 | 0 | 0 | 2 | 2 | 1 | 7 | 7 | 1 | 1 | |
Total Income | 186 | 197 | 201 | 210 | 292 | 326 | 417 | 664 | 681 | 692 | |
Total Expenditure | -166 | -168 | -170 | -176 | -250 | -282 | -362 | -521 | -561 | -578 | |
PBIDT | 20 | 29 | 30 | 33 | 42 | 44 | 55 | 143 | 120 | 114 | |
Interest | -7 | -8 | -8 | -8 | -8 | -8 | -7 | -8 | -13 | -20 | |
Depreciation | -9 | -9 | -9 | -11 | -11 | -11 | -12 | -16 | -18 | -24 | |
Taxation | -1 | -5 | -5 | -6 | -8 | -8 | -11 | -36 | -18 | -13 | |
Exceptional Items | |||||||||||
PAT | 2 | 8 | 8 | 8 | 15 | 16 | 25 | 83 | 71 | 57 | |
Adjusted EPS | 1 | 3 | 3 | 3 | 6 | 6 | 9 | 30 | 26 | 21 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 15 | 17 | 28 | 25 | 22 | 17 | 25 | 21 | 44 | 1 | |
Cash Fr. Inv. | -8 | -9 | -17 | -31 | -8 | -12 | -13 | -28 | -109 | -75 | |
Cash Fr. Finan. | -7 | -8 | -11 | 5 | -13 | 2 | -13 | 3 | 75 | 62 | |
Net Change | 0 | 1 | 0 | 0 | 0 | 7 | 0 | -4 | 10 | -12 | |
Cash & Cash Eqvt | 0 | 1 | 1 | 0 | 1 | 8 | 8 | 4 | 14 | 2 |
Mon, 29 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance Pursuant to Circular CIR/CFD/CMD1/27/2019 dated February 08 2019 for the purpose of compliance with Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith the Annual Secretarial Compliance Report for the year ended 31st March 2023.Kindly take the same on record. |
Fri, 26 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper advertisement for declaration of postal ballot result |
Wed, 24 May 2023
Board Meeting Intimation for Consideration And Approval Of Audited Financial Result For The Quarter And Year Ended March 31 2023 And To Recommend Final Dividend On Equity Shares If Any For The Financial Year Ended March 31 2023. Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 30th May 2023 inter alia to: -Consider and approve Audited Financial Result for the quarter and year ended March 31 2023.-Recommend final dividend on equity shares if any for the financial year ended March 31 2023.-Any other matter with the permission of the Chair.You are requested to take the same on record. |
Mon, 29 May 2023 |
|
|
|
|
|